.After revealing a phase 3 launch based on good midstage end results, iTeos and GSK are finally disc...
.The FDA should be actually more open as well as joint to unleash a surge in commendations of unusua...
.It's an abnormally occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Rehabs al...
.Atea Pharmaceuticals' antiviral has actually failed an additional COVID-19 trial, but the biotech s...
.Neurocrine Biosciences' schizophrenia program pivot has actually failed. The biotech was actually n...
.Sanofi has actually made a late entrance to the radioligand celebration, paying out one hundred tho...
.After F2G's 1st effort to acquire a new training class of antifungal to market was hindered by the ...
.Moderna has vowed to reduce R&D spending by $1.1 billion through 2027. The choice to retract the...
.Merely four months after Sanofi wager $80 million in ahead of time cash money on Key Therapies' los...
.Cancer business Oncternal Therapeutics is actually folding all its medical trials and giving up per...